Status:
RECRUITING
Chemotherapy Induced Neuropathy in Cancer Patients
Lead Sponsor:
Swami Rama Himalayan University
Conditions:
Chemotherapy-induced Peripheral Neuropathy
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this prospective study is to perform Nerve conduction test, Vitamin D, Vitamin B12 and NADPH oxidase 4(NOX4) expression to assess severity of chemotherapy induced Peripheral neuropathy ...
Detailed Description
A)Screening of neuropathy in Healthy subject and Solid cancer patient before receiving chemotherapy \& after 4th cycle of chemotherapy Patient who will be included in this study undergo complete neuro...
Eligibility Criteria
Inclusion
- All patients receiving chemotherapy for solid cancer
- Patient aged\>18years
Exclusion
- Age ≤ 18 years
- Pre-existing neuropathy
- Patients diagnosed with Psychiatric illness
- Patients with pre-existing peripheral neuropathy
- Patients taking medication for neuropathy
- Long standing diabetes (\>10 years)
- Renal and Hepatic disease
Key Trial Info
Start Date :
November 23 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 25 2024
Estimated Enrollment :
124 Patients enrolled
Trial Details
Trial ID
NCT06491082
Start Date
November 23 2022
End Date
August 25 2024
Last Update
July 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Himalayan Hospital(Cancer Research Institute), Himalayan Institute of Medical Sciences
Dehradun, India, 248016